Impact of complete remission with intensive therapy in patients with responsive multiple myeloma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Link
http://www.nature.com/articles/1703035.pdf
Reference26 articles.
1. Barlogie B, Alexanian R, Dicke K et al. High dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma Blood 1987 70: 868–872
2. Cunningham D, Pazares L, Gore M et al. High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated multiple myeloma J Clin Oncol 1994 12: 759–763
3. Alexanian R, Dimopoulos M, Hester J et al. Early myeloablative therapy for multiple myeloma Blood 1994 84: 4278–4282
4. Harousseau J, Attal M, Divine M et al. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma Blood 1995 85: 3077–3085
5. Attal M, Harousseau J, Stoppa J et al. Autologous bone marrow transplantation versus conventional chemotherapy in multiple myeloma New Engl J Med 1996 335: 91–97
Cited by 117 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical implications of measurable residual disease assessment in multiple myeloma in the era of quadruplet therapy;Leukemia & Lymphoma;2022-09-28
2. Bortezomib, Vorinostat, and Dexamethasone Combination Therapy in Relapsed Myeloma: Results of the Phase 2 MUK four Trial;Clinical Lymphoma Myeloma and Leukemia;2021-03
3. Impact of early reduction in paraprotein on survival in transplant ineligible myeloma: Lesson from a tertiary cancer center in rural India;Journal of Cancer Research and Therapeutics;2020
4. Benefits of additional cycles of bortezomib/thalidomide/dexamethasone (VTD) induction therapy compared to four cycles of VTD for newly diagnosed multiple myeloma;Bone Marrow Transplantation;2019-07-29
5. Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma;Blood Advances;2019-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3